Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Latency Antibiotics for Previable Rupture Of Membranes: LAPROM Trial

NCT06917157 is registered in ClinicalTrials.gov with The University of Texas Health Science Center, Houston as lead sponsor.

NCT NCT06917157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06917157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Latency Antibiotics for Previable Rupture Of Membranes: LAPROM Trial
Lead sponsor
The University of Texas Health Science Center, Houston
Phase
Phase 4
Overall status
Withdrawn
Start date
May 1, 2025
Completion date
May 31, 2027
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

preterm prelabor rupture of membranes (pprom)